Results 21 to 30 of about 75,548 (336)

Predictive Utility of Systemic Immune Inflammation Index (SII) in Identifying Endometrial Carcinoma in Premalignant Endometrial Lesions

open access: yesVan Tıp Dergisi, 2023
INTRODUCTION: It is important to detect endometrial cancer (EC) in endometrial intraepithelial neoplasia (EIN) patients. It was aimed to determine the role of systemic immune inflammation index (SII) in predicting concurrent EC in women with EIN. METHODS:
Caner Köse   +5 more
doaj   +1 more source

Co‐existing monophasic teratoma and uterine adenocarcinoma in a female dog [PDF]

open access: yes, 2019
Ovarian teratomas are occasionally reported in dogs; the rarest type is the monophasic teratoma,composed of tissues originating from only one germ layer. Canine endometrial adenocarcinomas are also rare in dogs and mainly affect geriatric females.
Catarino, J.C   +8 more
core   +2 more sources

Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations [PDF]

open access: yes, 2014
Somatic mitochondrial DNA (mtDNA) mutations have been found in a subset of endometrial cancers (EC) from different populations. We have investigated the relationship between mtDNA changes and clinical and pathological variables of women affected by ...
Bartnik, Ewa   +6 more
core   +1 more source

Primary endometrial B-Cell lymphoma: Rare etiology of abnormal uterine bleeding and potential nonsurgical therapy

open access: yesRadiology Case Reports, 2015
We present a case of primary endometrial B-cell lymphoma, pathologically confirmed. The patient is a 68-year-old female with postmenopausal bleeding. Ultrasound revealed endometrial thickening and was followed up with endometrial biopsy.
Jonathan Revels, DO   +2 more
doaj   +1 more source

Risk of cancer after assisted reproduction: a review of the available evidences and guidance to fertility counselors [PDF]

open access: yes, 2018
Infertile women requiring ovarian stimulation and assisted reproduction techniques (ART) are faced with difficult issues. The fear that using hormones could increase their risk of cancer is the most significant.
Codacci-Pisanelli, G   +4 more
core   +1 more source

Uterine adenocarcinoma with abdominal metastases in an ovariohysterectomised female cat [PDF]

open access: yes, 2011
An adenocarcinoma of the uterine stump with abdominal metastases is described in a 12-year-old incompletely ovariohysterectomised female Domestic Short Haired (DSH) cat.
Belter LF   +4 more
core   +1 more source

Endometrial cancer - reduce to the minimum. A new paradigm for adjuvant treatments?

open access: yesRadiation Oncology, 2011
Background Up to now, the role of adjuvant radiation therapy and the extent of lymph node dissection for early stage endometrial cancer are controversial.
Scheithauer Heike R   +2 more
doaj   +1 more source

Molecular Profiling of Endometrial Malignancies

open access: yesObstetrics and Gynecology International, 2010
Molecular profiling of endometrial neoplasms reveals genetic changes in endometrial carcinomas that support the dualistic model, in which type I carcinomas are estrogen-dependent, low grade lesions and type II carcinomas are nonestrogen dependent and ...
Norasate Samarnthai   +2 more
doaj   +1 more source

Synchronous Occurrence of Primary Neoplasms in the Uterus with Squamous Cell Carcinoma of the Cervix and Adenocarcinoma of the Endometrium

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2006
Objective: Synchronous primary malignant neoplasms of the uterus are uncommon. Patients with synchronous cervical and endometrial cancers are even rarer.
Cheng-Kuo Lin   +3 more
doaj   +1 more source

Lifestyle advice to reduce ovarian cancer risk [PDF]

open access: yesWorld Cancer Research Journal, 2020
OBJECTIVE: Ovarian cancer is usually diagnosed at advanced stages; it has one of the worst prognoses among gynecologic neoplasms and it hasn’t got an effective screening program. It has modifiable risk factors in common with endometrial and breast cancer.
L. Del Pup, L. Driul, F. Peccatori
doaj   +1 more source

Home - About - Disclaimer - Privacy